Skip to main content
. 2017 May 11;31(3):223–237. doi: 10.1007/s40259-017-0219-4

Fig. 6.

Fig. 6

Agreement of immunogenicity testing between Remicade- and CT-P13-tagged immunoassays for the detection of a ADAs and b NAbs in PLANETAS and PLANETRA pooled analysis. *Assay ADA-A = ADA detection immunoassay with EU-approved Remicade tag; assay ADA-B = ADA detection immunoassay with CT-P13 tag. **Assay NAb-A = NAb detection immunoassay with EU-approved Remicade tag; assay NAb-B = NAb detection immunoassay with CT-P13 tag. ADA antidrug antibody, CI confidence interval, EOS end of study, EU European Union, NAb neutralising antibody, RP reference product